Biotechnology and nanotechnology in Poland in 2022
A
A
A
In 2022, 187 firms conducted biotechnology activities, which constitutes an increase by 8.1% in comparison to the previous year. Biotechnology intramural expenditures incurred by firms amounted to PLN 1952.7 million and increased by 41.4% on an annual basis. In 2022, 4317 persons were employed in biotechnology in firms. Biotechnology research and experimental development was conducted by 234 entities, that is, by 7.8% more in comparison with the previous year. Biotechnology R&D intramural expenditures amounted to PLN 1432.4 million and increased by 20.9% annually. 8431 persons were involved in biotechnology research and experimental development.
70 firms, i.e. by 6.7% less than in the previous year, conducted nanotechnology activities. Intramural expenditures on nanotechnology incurred by firms amounted to PLN 485.9 million and were higher by 13.7% in comparison with the previous year. 3687 persons were employed in the field of nanotechnology, of which 1344 persons in firms. Research and experiemntal development in the field of nanotechnology were carried out by 125 entities, i.e. as many as a year ago. Nanotechnology R&D intramural expenditures amounted to PLN 399.9 million and were by 7.1% higher than in the previous year. 2817 persons were involved in nanotechnology research and experimental development.
